Roper Technolgies Aktie

584,83USD -1,12USD -0,19%
Roper Technolgies für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN: 883563 / ISIN: US7766961061
<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Personal

2020 2021 2022 2023 2024
Personal am Ende des Jahres 18 400 19 300 15 800 16 800 18 200
Umsatz pro Mitarbeiter in Mio. EUR 0,30 0,30 0,34 0,37 0,39

Bilanz (in Mio. USD) - Aktiva

2020 2021 2022 2023 2024
Summe Umlaufvermögen 1 752 2 397 1 901 1 446 1 502
Summe Anlagevermögen 22 273 21 317 25 080 26 721 29 833
Summe Aktiva 24 025 23 714 26 981 28 168 31 335

Bilanz (in Mio. USD) - Passiva

2020 2021 2022 2023 2024
Summe Fremdkapital 13 545 12 150 10 943 10 723 12 467
Summe Eigenkapital 10 480 11 564 16 038 17 445 18 868
Summe Passiva 24 025 23 714 26 981 28 168 31 335

Adresse

6496 University Parkway, 34240 Sarasota
Telefon +1 (941) 556-2601
Internet http://www.ropertech.com

Management

Amy Woods Brinkley
Independent Chairman
Brandon L. Cross
Vice President & Controller
Christopher Wright
Independent Director
Irene M. Esteves
Independent Director
Jason Phillip Conley
Chief Financial Officer & Executive Vice President
John Francis Murphy
Independent Director
John Kenneth Stipancich
Secretary, Executive VP & General Counsel
Laura G. Thatcher
Independent Director
Laurence Neil Hunn
President, Chief Executive Officer & Director
Michael P. Corkery
Senior Vice President
Richard F. Wallman
Independent Director
Robert D. Johnson
Independent Director
Satish Maripuri
Group Vice President-Software Businesses
Shannon O'Callaghan
Vice President-Finance
Shellye Louise Archambeau
Independent Director
Thomas Patrick Joyce
Independent Director
Zack Moxcey
Vice President-Investor Relations
Aktien ATX  DAX  EuroStoxx 50  Dow Jones  NASDAQ 100  Nikkei 225  S&P 500 

Weitere Aktien: Metro-Goldwyn-Mayer Pall CNF Kosan Biosciences Teligent AB

Kontakt  - Impressum - Werbung

Sitemap  - Datenschutz  - Disclaimer  - AGB  - Privatsphäre-Einstellungen